Clinical Utility of BDTM mCCDA ClearHT Agar Medium for Campylobacter jejuni

Mitsunori Kaneda; Kumiko Takesue; Keisuke Mori; Kiyoshi Kamiyama

Clinical Utility of BD^TM mCCDA ClearHT Agar Medium for Campylobacter jejuni

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2021 Dec 25;31(1):15-21.

Authors

Mitsunori Kaneda¹, Kumiko Takesue², Keisuke Mori², Kiyoshi Kamiyama²

Affiliations

¹ Department of Clinical Laboratory, Medical Diagnostic Center of URAWA Medical Association, 6‒4‒18 Tokiwa, Urawa-ku, Saitama 338‒0011, Japan. Department of Natural Sciences, Graduate School of Integrative Science and Engineering, Tokyo City University, 1‒28‒1 Tamatsutsumi, Setagaya-ku, Tokyo 158‒8557, Japan.
² Department of Clinical Laboratory, Medical Diagnostic Center of URAWA Medical Association, 6‒4‒18 Tokiwa, Urawa-ku, Saitama 338‒0011, Japan.

PMID: 34986643

Abstract

Campylobacter spp. has been the leading cause of bacterial food poisoning in Japan since 2000. The predominant Campylobacter spp. testing method employs selective medium to isolate Campylobacter spp. In the present study, we evaluated the Campylobacter-isolating capacity and clinical utility of BD^TM mCCDA Clear-HT, an agar medium containing a chromogenic substrate, on 230 diarrhea stool samples. After 48 hours incubation, 50 samples (21.7%) were positive with BD^TM mCCDA Clear-HT, while 61 samples (26.5%) were positive using modified Skirrow agar medium. In this study, BD^TM mCCDA Clear-HT had a lower detection rate of Campylobacter jejuni more than Vitalmedia modified Skirrow agar medium.

MeSH terms

Agar
Campylobacter jejuni*
Campylobacter*
Chromogenic Compounds
Culture Media

Substances

Chromogenic Compounds
Culture Media
Agar